Brief: Theranexus End-December Available Cash At 12.5 Million Euros
13/01/2022 17:48
Jan 13 (Reuters) - Theranexus SA ALTHX.PA :
* THE AVAILABLE CASH ON DECEMBER 31, 2021 AMOUNTED TO EUR
12.5
MILLION COMPARED TO 11.2 MEUR ON DECEMBER 31, 2020
Source text for Eikon: ID:nACT72755
Further company coverage: ALTHX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease